Drug Approval | February 08, 2022
Lupin receives approval from USFDA for Arformoterol Tartrate inhalation
Arformoterol Tartrate had estimated annual sales of US $ 251 million in the U.S. (IQVIA MAT December 2021)
Arformoterol Tartrate had estimated annual sales of US $ 251 million in the U.S. (IQVIA MAT December 2021)
This product will be manufactured at Lupin's Goa facility in India
It is indicated for the treatment of patients with acromegaly and Gastroenteropancreatic Neuroendocrine Tumours
Intox is a GLP certified pre-clinical contract research organization with its test facilities in Pune
FDA changes inspection classification of the facility to Voluntary Action Indicated
Gland Pharma believes that they are amongst one of the first to file for this product and may be eligible for 180 days of generic drug exclusivity
The product will be commercialized from Unichem's Ghaziabad plant
Obseva announced previously that the company has entered into a partnership with Syneos Health to support commercialization of linzagolix in the US and EU
The injection is used to reverse the effects of the muscle relaxants given to patients during surgery
This product will be manufactured at Lupin’s Pithampur facility In India
Subscribe To Our Newsletter & Stay Updated
